Where does Tolmar Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Tolmar Therapeutics, Inc. ranks #18,203 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Tolmar Therapeutics, Inc. hold?

Tolmar Therapeutics, Inc. holds 16 US utility patents granted between 2015 and 2021, spanning 10 technology areas.

What is Tolmar Therapeutics, Inc.'s Innovation Score?

Tolmar Therapeutics, Inc. has an Innovation Score of 28.3 out of 100 (27th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Tolmar Therapeutics, Inc. focus on?

Tolmar Therapeutics, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 13 patents, ranking #1,479 of 6,058 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

Is Tolmar Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Tolmar Therapeutics, Inc.'s recent grant velocity is -67% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Tolmar Therapeutics, Inc.'s patents?

Tolmar Therapeutics, Inc.'s patents average 12.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Tolmar Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Tolmar Therapeutics, Inc.

USPTO PatentsView assignee record - 16 granted patents across 10 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Tolmar ranks #18,203 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 10 technology areas.

#18,203
of 49,997 US assignees by volume: 27th percentile
by Innovation Score (28.3/100): 12.3
avg claims per patent: -67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18203 · US Corporation #18,203 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 16 grants
MID-PACK #18,203/49,997
PHOTO-FINISH Thumbtack
CPC-FOCUS A61P · 10 areas
INNOV-THIN 28.3/100
CLAIMS-RICH 12.3 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Thumbtack, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Tolmar’s 28.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (35%) Velocity 0.0 pts (0%) Breadth 11.2 pts (39%) Claim depth 7.4 pts (26%)

Qualcomm Incorporated · highest

85
Tolmar Therapeutics · this assignee

28
3D Lighting… · lowest

7

What this shows Tolmar's Innovation Score is 28.3/100 (27th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Tolmar?

Each dot is one of Tolmar’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Tolmar’s own 12.3 claims/patent is at or below the 13.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Tolmar vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Tolmar's grants concentrate

Tolmar Therapeutics, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 81.3% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (3 grants) versus a trough of 1 in 2019. By volume, Tolmar sits between Thumbtack, Inc. and Torrey Pines Institute for Molecular Studies.

Thumbtack

16
Tintometer

16
Tintri

16
Toko

16
Top Glory Trading…

16
Topia Technology

16
Torrent Pharmaceu…

16
Torrey Pines Inst…

16
Tolmar Therapeuti… ◀

16

What this shows Tolmar holds 16 patents at rank #18,216, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Tolmar

By rank, the assignees closest to #18,216 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Tolmar's primary technology class.

Tolmar's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 27th percentile higher than 27% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Tolmar Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	12.5%
2016	3	18.8%
2017	3	18.8%
2018	3	18.8%
2019	1	6.3%
2020	2	12.5%
2021	2	12.5%

Which technologies does Tolmar Therapeutics, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 13

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 13

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 10

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 6

C08L - Compositions OF Macromolecular Compounds 5

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 2

F26B - Drying Solid Materials OR Objects BY Removing Liquid Therefrom 2

F16B - Devices FOR Fastening OR Securing Constructional Elements OR Machine Parts Together, e.g. Nails, Bolts, Circlips, Clamps, Clips OR WEDGES; Joints OR Jointing 1

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Tolmar Therapeutics, Inc.'s patent record in context - here's where to go next.

Tolmar Therapeutics, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 81.3% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #18,203 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Tolmar Therapeutics, Inc. against Thumbtack, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.